Niraparib in Combination With Osimertinib in EGFR-Mutated Advanced Lung Cancer
Clinical trial NCT03891615 · UNKNOWN
Trial details
- NCT number
- NCT03891615
- Sponsor
- Massachusetts General Hospital
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-06
- Primary completion
- 2022-04-30
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.